OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting HER3 to overcome EGFR TKI resistance in NSCLC
Qiuqiang Chen, Gang Jia, Xilin Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Qiuqiang Chen, Gang Jia, Xilin Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Pharmacological Research (2024) Vol. 202, pp. 107123-107123
Open Access | Times Cited: 8
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Pharmacological Research (2024) Vol. 202, pp. 107123-107123
Open Access | Times Cited: 8
Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
Junjun Liu, Jianwei Zhu
International Immunopharmacology (2024) Vol. 138, pp. 112609-112609
Closed Access | Times Cited: 4
Junjun Liu, Jianwei Zhu
International Immunopharmacology (2024) Vol. 138, pp. 112609-112609
Closed Access | Times Cited: 4
Emerging Targets in Non-Small Cell Lung Cancer
Louisa Liu, Joshua Soler, Karen L. Reckamp, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10046-10046
Open Access | Times Cited: 2
Louisa Liu, Joshua Soler, Karen L. Reckamp, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10046-10046
Open Access | Times Cited: 2
Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review
Ionas Papassotiriou, Antonios Kapogiannatos, C. Makatsoris, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5489-5489
Open Access | Times Cited: 2
Ionas Papassotiriou, Antonios Kapogiannatos, C. Makatsoris, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5489-5489
Open Access | Times Cited: 2
Recombinant retroviral vectors that express EGF, TGF alpha, NRG2 beta, and the NRG2 beta Q43L mutant v2
Ella Wilson
(2024)
Open Access | Times Cited: 1
Ella Wilson
(2024)
Open Access | Times Cited: 1
Assessing the Anticancer Potential of Compounds from Caesalpinia sappan Wood against Mutant EGFR in Lung Squamous Cell Carcinoma: Computational Insights
Shaik Pashmina, Nitya Krishnasamy, Suganya Panneer Selvam, et al.
Journal of Pharmacology and Pharmacotherapeutics (2024)
Open Access
Shaik Pashmina, Nitya Krishnasamy, Suganya Panneer Selvam, et al.
Journal of Pharmacology and Pharmacotherapeutics (2024)
Open Access
